Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Express Scripts (ESRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Express Scripts ONE EXPRESS WAY ST. LOUIS MO 63121 USA

www.express-scripts.com P: 314-996-0900 F: 314-770-2378

Description:

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company. It operates in two segments, PBM and Other Business Operations. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services. This segment also provides Medicare, Medicaid, health insurance marketplace products etc. The Other Business Operations segment distributes pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides consulting services, such as design, implementation, and project management for pharmaceutical and biotechnology manufacturers to collect scientific evidence to guide the use of medicines.

Key Statistics

Overview:

Market Capitalization, $K 45,434,200
Shares Outstanding, K 566,370
Annual Sales, $ 100,288 M
Annual Net Income, $ 3,404 M
Last Quarter Sales, $ 24,683 M
Last Quarter Net Income, $ 841,700 K
36-Month Beta 0.87
% of Insider Shareholders 0.68%
% of Institutional Shareholders 88.21%

Growth:

1-Year Total Return 10.72%
3-Year Total Return -5.40%
5-Year Total Return 48.12%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.90 on 10/24/17
Next Earnings Date 02/27/18
Earnings Per Share ttm 6.84
EPS Growth vs. Prev Qtr 9.83%
EPS Growth vs. Prev Year 9.20%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 2-1 on 06/08/10

ESRX Ratios

Ratio
Price/Earnings ttm 11.70
Price/Earnings forward 8.58
Price/Earnings to Growth 0.89
Return on Equity % 25.46
Return on Assets % 7.95
Net Margin % 2.87
Debt/Equity 0.86
Price/Sales 0.48
Price/Cash Flow 7.97
Price/Book 2.85
Book Value/Share 28.11
Interest Coverage 10.10
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.